• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的组织病理学。

Histopathology of nonalcoholic fatty liver disease.

机构信息

Department of Pathology and Immunology, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8118, St. Louis, MO 63110, United States.

出版信息

World J Gastroenterol. 2010 Nov 14;16(42):5286-96. doi: 10.3748/wjg.v16.i42.5286.

DOI:10.3748/wjg.v16.i42.5286
PMID:21072891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2980677/
Abstract

Histological analysis of liver biopsies remains a standard against which other methods of assessment for the presence and amount of hepatic injury due to nonalcoholic fatty liver disease (NAFLD) are measured. Histological evaluation remains the sole method of distinguishing steatosis from advanced forms of NAFLD, i.e. nonalcoholic steatohepatitis (NASH) and fibrosis. Included in the lesions of NAFLD are steatosis, lobular and portal inflammation, hepatocyte injury in the forms of ballooning and apoptosis, and fibrosis. However, patterns of these lesions are as distinguishing as the lesions themselves. Liver injury in adults and children due to NAFLD may have different histological patterns. In this review, the rationale for liver biopsy, as well as the histopathological lesions, the microscopically observable patterns of injury, and the differential diagnoses of NAFLD and NASH are discussed.

摘要

肝活检的组织学分析仍然是评估非酒精性脂肪性肝病 (NAFLD) 引起的肝损伤存在和程度的其他方法的标准。组织学评估仍然是区分脂肪变性与非酒精性脂肪性肝炎 (NASH) 和纤维化等 NAFLD 高级形式的唯一方法。NAFLD 的病变包括脂肪变性、肝小叶和门脉炎症、气球样变和凋亡形式的肝细胞损伤以及纤维化。然而,这些病变的模式与病变本身一样具有鉴别意义。由于 NAFLD,成人和儿童的肝损伤可能具有不同的组织学模式。在这篇综述中,讨论了肝活检的基本原理,以及组织病理学病变、可观察到的损伤显微镜模式以及 NAFLD 和 NASH 的鉴别诊断。

相似文献

1
Histopathology of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的组织病理学。
World J Gastroenterol. 2010 Nov 14;16(42):5286-96. doi: 10.3748/wjg.v16.i42.5286.
2
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
3
Histopathology, grading and staging of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的组织病理学、分级与分期
Minerva Gastroenterol Dietol. 2018 Mar;64(1):28-38. doi: 10.23736/S1121-421X.17.02445-X. Epub 2017 Sep 25.
4
Design and validation of a histological scoring system for nonalcoholic fatty liver disease.非酒精性脂肪性肝病组织学评分系统的设计与验证
Hepatology. 2005 Jun;41(6):1313-21. doi: 10.1002/hep.20701.
5
Histopathological Diagnosis of Nonalcoholic Steatohepatitis (NASH).非酒精性脂肪性肝炎(NASH)的组织病理学诊断。
Methods Mol Biol. 2022;2455:1-18. doi: 10.1007/978-1-0716-2128-8_1.
6
Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.代谢综合征与非酒精性脂肪性肝病患儿肝组织学的关系。
Am J Gastroenterol. 2010 Sep;105(9):2093-102. doi: 10.1038/ajg.2010.152. Epub 2010 Apr 6.
7
Non-alcoholic steatohepatitis in children.儿童非酒精性脂肪性肝炎
Pediatr Transplant. 2004 Dec;8(6):613-8. doi: 10.1111/j.1399-3046.2004.00241.x.
8
Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease.肝脂肪变类型、程度和区域性与儿童非酒精性脂肪性肝病组织学特征的关系。
J Pediatr Gastroenterol Nutr. 2011 Feb;52(2):190-7. doi: 10.1097/MPG.0b013e3181fb47d3.
9
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.非酒精性脂肪性肝病(NAFLD)中的门静脉慢性炎症:非酒精性脂肪性肝炎临床研究网络的晚期NAFLD组织学标志物——临床病理相关性
Hepatology. 2009 Mar;49(3):809-20. doi: 10.1002/hep.22724.
10
Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的组织病理学
Metabolism. 2016 Aug;65(8):1080-6. doi: 10.1016/j.metabol.2015.11.008. Epub 2015 Dec 2.

引用本文的文献

1
Hepatocyte-specific angiotensinogen deficiency inhibits Western diet-induced liver steatosis with suppression of cell division in mice.肝细胞特异性血管紧张素原缺乏通过抑制小鼠细胞分裂来抑制西方饮食诱导的肝脏脂肪变性。
Glob Transl Med. 2025;4(2):71-85. doi: 10.36922/gtm.6027. Epub 2025 Apr 10.
2
Co-treatment of trigonelline and everolimus synergistically prevented chronic steatohepatitis induced by fast food diet and thioacetamide in a novel murine nonalcoholic steatohepatitis model.在一种新型小鼠非酒精性脂肪性肝炎模型中,胡芦巴碱与依维莫司联合治疗可协同预防由快餐饮食和硫代乙酰胺诱导的慢性脂肪性肝炎。
Indian J Pharmacol. 2025 Jul 1;57(4):234-241. doi: 10.4103/ijp.ijp_323_23. Epub 2025 Jul 21.
3
Pathogenesis and Clinical Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病的发病机制与临床管理
Int J Mol Sci. 2025 Jun 14;26(12):5717. doi: 10.3390/ijms26125717.
4
Nicotinamide Adenine Dinucleotide Phosphate Oxidases and Metabolic Dysfunction-Associated Steatotic Liver Disease.烟酰胺腺嘌呤二核苷酸磷酸氧化酶与代谢功能障碍相关脂肪性肝病
Antioxidants (Basel). 2025 Jan 13;14(1):83. doi: 10.3390/antiox14010083.
5
Towards linking histological changes to liver viscoelasticity: a hybrid analytical-computational micromechanics approach.将组织学变化与肝脏粘弹性联系起来:一种混合分析-计算微观力学方法。
Phys Med Biol. 2025 Feb 4;70(4). doi: 10.1088/1361-6560/adaad3.
6
Towards Linking Histological Changes to Liver Viscoelasticity: A Hybrid Analytical-Computational Micromechanics Approach.将组织学变化与肝脏粘弹性联系起来:一种混合分析-计算微观力学方法。
ArXiv. 2025 Jan 2:arXiv:2411.13530v3.
7
miRNA biomarkers to predict risk of primary non-function of fatty allografts and drug induced acute liver failures.用于预测脂肪移植物原发性无功能和药物性急性肝衰竭风险的微小RNA生物标志物。
Mol Cell Biochem. 2025 Apr;480(4):2573-2593. doi: 10.1007/s11010-024-05129-3. Epub 2024 Oct 18.
8
Relationships between tumor CD147 expression, tumor-infiltrating lymphocytes, and oncostatin M in hepatocellular carcinoma.肝细胞癌中肿瘤CD147表达、肿瘤浸润淋巴细胞与抑瘤素M之间的关系
Virchows Arch. 2024 Oct 12. doi: 10.1007/s00428-024-03939-w.
9
Understanding Insulin Resistance in NAFLD: A Systematic Review and Meta-Analysis Focused on HOMA-IR in South Asians.理解非酒精性脂肪性肝病中的胰岛素抵抗:一项聚焦于南亚人胰岛素抵抗指数的系统评价和荟萃分析
Cureus. 2024 Oct 3;16(10):e70768. doi: 10.7759/cureus.70768. eCollection 2024 Oct.
10
Adverse Outcome Pathways Mechanistically Describing Hepatotoxicity.不良结局途径对肝毒性的机制描述。
Methods Mol Biol. 2025;2834:249-273. doi: 10.1007/978-1-0716-4003-6_12.

本文引用的文献

1
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.使用肝硬度测量诊断非酒精性脂肪性肝病中的纤维化和肝硬化。
Hepatology. 2010 Feb;51(2):454-62. doi: 10.1002/hep.23312.
2
Transient elastography in nonalcoholic fatty liver disease: making sense of echoes.非酒精性脂肪性肝病中的瞬时弹性成像:解读回声
Hepatology. 2010 Feb;51(2):370-2. doi: 10.1002/hep.23422.
3
Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning.过氧化物酶体增殖物激活受体 γ 辅激活因子 1α 在非酒精性脂肪性肝病发病机制中的作用及其与胰岛素抵抗的关系
J Atheroscler Thromb. 2009;16(6):893-901. doi: 10.5551/jat.2055. Epub 2009 Dec 22.
4
Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.非酒精性脂肪性肝炎肝硬化肝移植后复发疾病。
Liver Transpl. 2009 Dec;15(12):1843-51. doi: 10.1002/lt.21943.
5
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的 HFE 基因型、实质铁积累和肝纤维化。
Gastroenterology. 2010 Mar;138(3):905-12. doi: 10.1053/j.gastro.2009.11.013. Epub 2009 Nov 18.
6
Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial.罗格列酮治疗非酒精性脂肪性肝炎的长期疗效:罗格列酮治疗(FLIRT 2 扩展试验)的脂肪肝改善结果。
Hepatology. 2010 Feb;51(2):445-53. doi: 10.1002/hep.23270.
7
Non-alcoholic fatty liver disease: is bariatric surgery the answer?非酒精性脂肪性肝病:减肥手术是解决之道吗?
Clin Liver Dis. 2009 Nov;13(4):689-710. doi: 10.1016/j.cld.2009.07.012.
8
Epidemiology and natural history of non-alcoholic steatohepatitis.非酒精性脂肪性肝炎的流行病学与自然史
Clin Liver Dis. 2009 Nov;13(4):511-31. doi: 10.1016/j.cld.2009.07.005.
9
The incapacity of the surgeon to identify NASH in bariatric surgery makes biopsy mandatory.外科医生无法在减重手术中识别 NASH,因此必须进行活检。
Obes Surg. 2009 Dec;19(12):1678-84. doi: 10.1007/s11695-009-9980-x.
10
Advances in pediatric nonalcoholic fatty liver disease.小儿非酒精性脂肪性肝病的进展
Hepatology. 2009 Oct;50(4):1282-93. doi: 10.1002/hep.23119.